Dermata Therapeutics, Inc. Warrant (DRMAW)
Dermata Therapeutics, Inc. Warrant (DRMAW) has a 16-report earnings history dating back to Aug 15, 2022. Its average absolute post-earnings move is ±0.02%, and 100.0% of those reactions were positive. Its largest post-earnings gain was +0.35% (Aug 10, 2023) and its largest decline was +0% (Aug 11, 2026). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How DRMAW moved on each past earnings report.
Earnings Impact
Total Earnings
16
Avg Abs. Movement
±0.02%
Positive %
100.0%
Negative %
0.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 11, 2026 | ☽ POST | +0% | — |
| Mar 26, 2026 | ☽ POST | +0% | open_in_new |
| Nov 14, 2025 | ☽ POST | +0% | open_in_new |
| Aug 13, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
16
Total earnings in dataset
Avg Abs. Movement
±0.02%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 25-NSE | 20260817 | open_in_new SEC.gov |
| 8-K | 20260817 | open_in_new SEC.gov |
| 10-Q | 20260811 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| 8-K | 20260805 | open_in_new SEC.gov |
| 4 | 20260616 | open_in_new SEC.gov |
| S-8 | 20260604 | open_in_new SEC.gov |
| SCHEDULE 13D | 20260601 | open_in_new SEC.gov |
Frequently asked about DRMAW earnings
When does Dermata Therapeutics, Inc. Warrant report earnings next? expand_more
Dermata Therapeutics, Inc. Warrant (DRMAW)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DRMAW stock move after earnings? expand_more
Over 16 reports, DRMAW has moved an average of ±0.02% the session after earnings, closing higher 100.0% of the time.
What was DRMAW's biggest post-earnings move? expand_more
DRMAW's largest post-earnings gain on record was +0.35% on Aug 10, 2023, and its largest decline was +0% on Aug 11, 2026.
Where can I find Dermata Therapeutics, Inc. Warrant's SEC filings? expand_more
All of Dermata Therapeutics, Inc. Warrant's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right